SELLAS Life Sciences (SLS) Inventory Average (2013 - 2015)
SELLAS Life Sciences (SLS) reported Inventory Average of $1.0 million for Q2 2015, up 160.81% year-over-year from $395500.0 in Q2 2014, and up 59.67% on a QoQ basis from $646000.0 in Q1 2015.
SELLAS Life Sciences (SLS) has 3 years of Inventory Average data on file, last reported at $1.0 million in Q2 2015.
- Quarterly Inventory Average rose 160.81% year-over-year to $1.0 million in Q2 2015, while the trailing twelve-month figure through Jun 2015 was $1.0 million (up 160.81% YoY) and the FY2014 annual result came in at $520500.0, changed N/A from the prior year.
- Inventory Average improved to $1.0 million in Q2 2015 per SLS's latest filing, from $646000.0 in the prior quarter.
- Across five years, Inventory Average topped out at $1.0 million in Q2 2015 and bottomed at $372000.0 in Q1 2014.
- The 3-year median for Inventory Average is $423500.0 (2013), against an average of $529125.0.
- The widest annual swing landed in 2014, when Inventory Average climbed 13.64%; it then soared 160.81% in 2015.
- Tracing SLS's Inventory Average over 3 years: stood at $405500.0 in 2013, then soared by 36.25% to $552500.0 in 2014, then jumped by 86.7% to $1.0 million in 2015.
- Per Business Quant, the three latest SLS Inventory Average figures stand at $1.0 million (Q2 2015), $646000.0 (Q1 2015), and $552500.0 (Q4 2014).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 83.37 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2015 | 1.03 Mn |
| Mar 31, 2015 | 646,000.00 |
| Dec 31, 2014 | 552,500.00 |
| Sep 30, 2014 | 441,500.00 |
| Jun 30, 2014 | 395,500.00 |
| Mar 31, 2014 | 372,000.00 |
| Dec 31, 2013 | 405,500.00 |
| Sep 30, 2013 | 388,500.00 |